Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant
Capitan Orthopedics, Inc. has received Breakthrough Device Designation from the FDA for its SupraSpacer™ implant, aimed at addressing the challenges of irreparable rotator cuff tears. The implant is designed to restore joint alignment and enable pain-free range of motion while preserving future surgical options. This innovative technology fills a significant gap in the care available for patients under 60 who experience severe rotator cuff injuries.
GRAND RAPIDS, Mich., April 30, 2026 /PRNewswire/ — Capitan Orthopedics, Inc. (https://capitanortho.com/) announced today that it has been granted Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its SupraSpacerTM implant. Today, over 2 million people a…